Skip to main content

Month: January 2025

Sodexo – Interim report on liquidity contract as of December 31, 2024

Regulated informationIssy-les-Moulineaux, January 20, 2025 Interim report on liquidity contract as of December 31, 2024 Under the liquidity contract entrusted by Sodexo to BNP Paribas Arbitrage, the following assets were booked to the liquidity account as of December 31, 2024:25,392 shares €14,423,130During the 2nd semester, the following were traded: Bought: 359,601 shares for €28,862,832 (4,110 transactions)Sold: 363,244 shares for €29,334,581 (4,498 transactions) As a reminder, 1 – The liquidity contract concluded with Exane BNP Paribas dated March 10, 2020, and modified by amendment of July 22, 2021, was suspended from August 25, 2023 pending the renewal of the resolution of the annual general meeting of the shareholders authorizing share buybacks by the next annual general meeting. As of August 24, 2023, after market...

Continue reading

Vicat – Liquidity contract situation as of 20241231

Half yearly report on the liquidity contract between VICAT and NATIXIS ODDO BHF Under the liquidity contract entrusted by VICAT to NATIXIS ODDO BHF, the following resources appeared in the dedicated liquidity account as of 31/12/2024:17,703 shares €1,429,046.9When the contract was set up, the following resources were listed in the dedicated liquidity account:25,553 shares €2,527,226.1Over the period 01/07/2024 to 31/12/2024, the following transactions were executed:Buy: 4,113 transactions Sell: 3,853 transactionsOver the same period, traded volumes amounted to:Buy: 315,885 shares to €10,864,434.2 Sell: 327,048 shares to €11,306,186.7ContactsInvestor relations contactPierre PedrosaTel.: +33 (0)6 73 25 98 06pierre.pedrosa@vicat.fr Press contactRaphael HinningerTel.: +33 (0)7 61 74 86 52raphael.hinninger@vicat.frAbout...

Continue reading

Auriant Mining AB’s application for delisting has been approved

As previously announced, on 17 January 2025 Auriant Mining AB (publ.) (the “Company”) applied for delisting of the Company’s shares from Nasdaq First North Growth Market.  Nasdaq has now approved the application and decided that the last day of trading will be 3 February 2025. For more information, please contact: Danilo Lange, CEOtel: +7 495 109 02 82e-mail: d.lange@auriant.com Company name: Auriant Mining ABShort name: AURISIN-code: SE0001337213 Website: www.auriant.com Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in the Republic of Tyva, Zabaikalye and the Republic of Khakassia. The company has currently four assets, including two operating mines (Tardan and Alluvial at Staroverinskaya), one early stage exploration asset and one development asset. Since...

Continue reading

PRESS RELEASE: BIGBEN: THIRD QUARTER 2024/25 SALES OF €87.7 MILLION

                                                Press release       Lesquin, 20 January 2025, 6.00pm CET THIRD QUARTER 2024/25 SALES OF €87.7 MILLION Bigben Interactive (ISIN FR0000074072) has today announced its consolidated sales for the first nine months of the 2024/25 financial year (nine months from 1 April to 31 December 2024).IFRS (€ million) 2024/252023/24% changeSalesFirst quarter (April-June) 57.9 63.5 -8.9%       Second quarter (July-September) 78.0 64.5 +20.8%       Third quarter (October-December) (1) 87.7 94.1 -6.8%       NACON Gaming 52.9 59.0 -10.3%Bigben AudioVideo/Telco 34.8 35.1 -0.9%       First nine months (April-December) (1) 223.6 222.2 +0.6%       NACON Gaming 129.9 126.7 +2.5%Bigben AudioVideo/Telco 93.7 95.4 -1.8%       (1)   Unaudited figures NACON Gaming’s...

Continue reading

PRESS RELEASE: NACON: THIRD QUARTER 2024/25 SALES: €52.9 MILLION

                                                Press release Lesquin, 20 January 2025, 6.00pm CET THIRD QUARTER 2024/25 SALES: €52.9 MILLION NACON (ISIN FR0013482791) has today reported its consolidated sales for the first nine months of the 2024/25 financial year (nine months from 1 April 2024 to 31 December 2024).Sales2024/252023/24Change         € millionFirst quarter (April-June) 32.3 35.5 -9.0%Second quarter (July-September) 44.8 32.3 +38.5%Third quarter (October-December) (1) 52.9 59.0 -10.3%Gaming 25.4 33.3 -23.7%Accessories 25.2 23.9 +5.3%Other(2) 2.3 1.8 +28.4%IFRS sales in the first nine months (April-December)(1) 129.9 126.7 +2.5%Gaming 71.1 74.6 -4.6%Accessories 54.2 48.8 +11.1%Other(2) 4.5 3.3 +35.8%(1)   Unaudited figures(2)   Mobile and Audio sales Third-quarter 2024/25 sales:...

Continue reading

Aramis Group – Declaration of transactions on own shares conducted from Jan 13 to Jan 17, 2025

PRESS RELEASE Arcueil, January 20, 2025 Declaration of transactions on own shares conducted from January 13 to January 17, 2025 Within the framework of the authorizations granted by the General Assembly on February 9, 2024, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from January 13 to January 17, 2025 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2025-01-13 FR0014003U94 14,583 7.5397 XPARAramis Group 9695002Q984W0T41WB42 2025-01-14 FR0014003U94 14,001...

Continue reading

Ensurge Micropower ASA – Business Update and contemplated Private Placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, Norway, 20 January 2025 – Ensurge Micropower ASA (“Ensurge” or the “Company”) (OSE: ENSU, and OTCQB: ENMPY) has made significant advancements in developing and producing the solid-state microbatteries.  Key Progress and AchievementsEncapsulation: Ensurge has resolved the encapsulation issues of the battery stack through process optimization and material selection. Battery performance: Ensurge is validating improvements to address leakage-related yield loss that will ensure high performance...

Continue reading

Finland welcomes Virtune with the First Five Crypto ETPs listed on Nasdaq Helsinki traded in euro

Helsinki, January 20th, 2025 – Virtune, the Swedish regulated crypto asset manager, today announced the listing of Finland’s first crypto exchange-traded products (ETP) on Nasdaq Helsinki. This makes it easy and secure for Finnish investors to invest in crypto assets through proven and well-established financial instruments in the local currency. Virtune has made history as the first company to list crypto Exchange Traded Products (ETPs) on Nasdaq Helsinki. This groundbreaking launch introduces multiple crypto ETPs to the Finnish market, marking a significant first for the country’s financial sector. The ETPs are now trading in euro and are accessible to investors through major Nordic financial institutions, including Nordnet and other established brokers. This launch represents several key firsts for Finland’s financial...

Continue reading

Schouw & Co. share buy-back programme, week 3 2025

On 2 January 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 70 of 23 December 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 50 million during the period 2 January to 31 March 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 10  January 2025 11,700 549.74 6,431,987    Monday, 13 January 2025 1,900 539.53 1,025,107    Tuesday, 14 January 2025 1,900 539.48 1,025,012    Wednesday, 15 January 2025 1,900 542.49 1,030,731    Thursday, 16 January 2025 1,900 544.69 1,034,911    Friday,...

Continue reading

PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel

TORONTO, Jan. 20, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has executed an agreement with Merhavim Mental Health Centre of Beer Yaakov, Israel (“Merhavim”). All data generated in the clinical trial, entitled “MDMA Assisted Psychotherapy for PTSD of Early Sexual Trauma Compared to All Trauma in Adulthood”, will be licensed to PharmAla for regulatory and commercial purposes in exchange for the clinical trial material, which will be provided by PharmAla on a zero-cost basis. MAPS Israel, an Israeli non-profit organization whose mission is to develop psychedelic research and educational...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.